Loading...
Vivos Therapeutics, Inc.
VVOS•NASDAQ
Healthcare
Medical - Devices
$6.77
$0.77(12.75%)
Vivos Therapeutics, Inc. (VVOS) Financial Performance & Statements
Review Vivos Therapeutics, Inc.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
8.91%
↑ 8.91%
Operating Income Growth
35.41%
↑ 35.41%
Net Income Growth
18.02%
↑ 18.02%
Operating Cash Flow Growth
-6.24%
↓ 6.24%
Operating Margin
-76.07%
↓ 76.07%
Gross Margin
58.73%
↑ 58.73%
Net Profit Margin
-76.82%
↓ 76.82%
ROE
-170.43%
↓ 170.43%
ROIC
-169.09%
↓ 169.09%
Vivos Therapeutics, Inc. (VVOS) Financial Statements
Explore quarterly and annual reports for Vivos Therapeutics, Inc. stock.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $3.70M | $3.86M | $4.05M | $3.42M |
| Cost of Revenue | $1.60M | $1.53M | $1.40M | $1.48M |
| Gross Profit | $2.10M | $2.33M | $2.65M | $1.94M |
| Gross Profit Ratio | $0.57 | $0.60 | $0.65 | $0.57 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $100000.00 |
| SG&A Expenses | $4.76M | $4.83M | $4.44M | $5.58M |
| Operating Expenses | $4.90M | $4.98M | $4.44M | $5.58M |
| Total Costs & Expenses | $6.46M | $6.50M | $5.99M | $7.06M |
| Interest Income | $0.00 | $0.00 | $0.00 | $0.00 |
| Interest Expense | $0.00 | $0.00 | $0.00 | $0.00 |
| Depreciation & Amortization | $144000.00 | $146000.00 | $145000.00 | $146000.00 |
| EBITDA | -$2.68M | -$2.50M | -$1.79M | -$3.64M |
| EBITDA Ratio | -$0.73 | -$0.65 | -$0.44 | -$1.06 |
| Operating Income | -$2.81M | -$2.65M | -$1.94M | -$3.64M |
| Operating Income Ratio | -$0.76 | -$0.69 | -$0.48 | -$1.06 |
| Other Income/Expenses (Net) | -$21000.00 | $29000.00 | $6000.00 | $22000.00 |
| Income Before Tax | -$2.83M | -$2.62M | -$1.93M | -$3.76M |
| Income Before Tax Ratio | -$0.76 | -$0.68 | -$0.48 | -$1.10 |
| Income Tax Expense | $0.00 | $0.00 | $0.00 | $1.44M |
| Net Income | -$2.83M | -$2.62M | -$1.93M | -$3.76M |
| Net Income Ratio | -$0.76 | -$0.68 | -$0.48 | -$1.10 |
| EPS | $1.26 | -$0.40 | -$0.60 | -$1.63 |
| Diluted EPS | $1.26 | -$0.40 | -$0.60 | -$1.63 |
| Weighted Avg Shares Outstanding | $5.89M | $6.62M | $3.23M | $2.31M |
| Weighted Avg Shares Outstanding (Diluted) | $5.89M | $6.62M | $3.23M | $2.31M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan